110 related articles for article (PubMed ID: 20087861)
1. Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort.
Stocks T; Hergens MP; Englund A; Ye W; Stattin P
Int J Cancer; 2010 Oct; 127(7):1660-8. PubMed ID: 20087861
[TBL] [Abstract][Full Text] [Related]
2. Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.
Möller E; Wilson KM; Batista JL; Mucci LA; Bälter K; Giovannucci E
Int J Cancer; 2016 Feb; 138(4):853-65. PubMed ID: 26355806
[TBL] [Abstract][Full Text] [Related]
3. Lifetime body size and prostate cancer risk in a population-based case-control study in Sweden.
Möller E; Adami HO; Mucci LA; Lundholm C; Bellocco R; Johansson JE; Grönberg H; Bälter K
Cancer Causes Control; 2013 Dec; 24(12):2143-55. PubMed ID: 24048969
[TBL] [Abstract][Full Text] [Related]
4. Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers.
Andersson SO; Wolk A; Bergström R; Adami HO; Engholm G; Englund A; Nyrén O
J Natl Cancer Inst; 1997 Mar; 89(5):385-9. PubMed ID: 9060961
[TBL] [Abstract][Full Text] [Related]
5. Prospective study on metabolic factors and risk of prostate cancer.
Häggström C; Stocks T; Ulmert D; Bjørge T; Ulmer H; Hallmans G; Manjer J; Engeland A; Nagel G; Almqvist M; Selmer R; Concin H; Tretli S; Jonsson H; Stattin P
Cancer; 2012 Dec; 118(24):6199-206. PubMed ID: 23090855
[TBL] [Abstract][Full Text] [Related]
6. Midlife metabolic factors and prostate cancer risk in later life.
Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Wilson KM; Steingrimsdottir L; Aspelund T; Batista JL; Fall K; Giovannucci E; Sigurdardottir LG; Tryggvadottir L; Gudnason V; Markt SC; Mucci LA
Int J Cancer; 2018 Mar; 142(6):1166-1173. PubMed ID: 29114858
[TBL] [Abstract][Full Text] [Related]
7. Obesity, hypertension, and the risk of kidney cancer in men.
Chow WH; Gridley G; Fraumeni JF; Järvholm B
N Engl J Med; 2000 Nov; 343(18):1305-11. PubMed ID: 11058675
[TBL] [Abstract][Full Text] [Related]
8. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Rodriguez C; Freedland SJ; Deka A; Jacobs EJ; McCullough ML; Patel AV; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):63-9. PubMed ID: 17179486
[TBL] [Abstract][Full Text] [Related]
9. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
10. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.
Gann PH; Ma J; Giovannucci E; Willett W; Sacks FM; Hennekens CH; Stampfer MJ
Cancer Res; 1999 Mar; 59(6):1225-30. PubMed ID: 10096552
[TBL] [Abstract][Full Text] [Related]
11. Serum calcium and the risk of prostate cancer.
Halthur C; Johansson AL; Almquist M; Malm J; Grönberg H; Manjer J; Dickman PW
Cancer Causes Control; 2009 Sep; 20(7):1205-14. PubMed ID: 19377857
[TBL] [Abstract][Full Text] [Related]
12. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality.
Wright ME; Chang SC; Schatzkin A; Albanes D; Kipnis V; Mouw T; Hurwitz P; Hollenbeck A; Leitzmann MF
Cancer; 2007 Feb; 109(4):675-84. PubMed ID: 17211863
[TBL] [Abstract][Full Text] [Related]
13. Interrelation of energy intake, body size, and physical activity with prostate cancer in a large prospective cohort study.
Platz EA; Leitzmann MF; Michaud DS; Willett WC; Giovannucci E
Cancer Res; 2003 Dec; 63(23):8542-8. PubMed ID: 14679023
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of trans-fatty acid levels in blood and risk of prostate cancer.
Chavarro JE; Stampfer MJ; Campos H; Kurth T; Willett WC; Ma J
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):95-101. PubMed ID: 18199715
[TBL] [Abstract][Full Text] [Related]
15. Anthropometrics and prostate cancer risk.
Littman AJ; White E; Kristal AR
Am J Epidemiol; 2007 Jun; 165(11):1271-9. PubMed ID: 17395597
[TBL] [Abstract][Full Text] [Related]
16. A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer.
Hammarsten J; Damber JE; Peeker R; Mellström D; Högstedt B
Cancer Epidemiol; 2010 Oct; 34(5):574-9. PubMed ID: 20702155
[TBL] [Abstract][Full Text] [Related]
17. Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men.
Larsson SC; Akesson A; Wolk A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1939-41. PubMed ID: 19505926
[TBL] [Abstract][Full Text] [Related]
18. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
19. Weight change and prostate cancer incidence and mortality.
Bassett JK; Severi G; Baglietto L; MacInnis RJ; Hoang HN; Hopper JL; English DR; Giles GG
Int J Cancer; 2012 Oct; 131(7):1711-9. PubMed ID: 22213024
[TBL] [Abstract][Full Text] [Related]
20. Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Rodriguez C; Jacobs EJ; Deka A; Patel AV; Bain EB; Thun MJ; Calle EE
Cancer Causes Control; 2009 Jul; 20(5):671-9. PubMed ID: 19067188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
